Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients
DNA
By Dr. Sushama R. Chaphalkar, PhD. Reviewed by Susha Cheriyedath, M.Sc. Nov 17 2024 Researchers unveil a groundbreaking DNA vaccine that supercharges immunity and boosts survival in patients with aggressive breast cancer—could this be the future of personalized cancer treatment? Study: Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients . Image Credit: Nemes Laszlo / Shutterstock In a recent study published in the
din zilele anterioare